Artykuły w czasopismach na temat „PDE”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „PDE”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Bloom, Timothy J. "Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle". Canadian Journal of Physiology and Pharmacology 80, nr 12 (1.12.2002): 1132–35. http://dx.doi.org/10.1139/y02-149.
Pełny tekst źródłaDAY, Jonathan P., Julian A. T. DOW, Miles D. HOUSLAY i Shireen-A. DAVIES. "Cyclic nucleotide phosphodiesterases in Drosophila melanogaster". Biochemical Journal 388, nr 1 (10.05.2005): 333–42. http://dx.doi.org/10.1042/bj20050057.
Pełny tekst źródłaWright, Lyndon C., Joachim Seybold, Annette Robichaud, Ian M. Adcock i Peter J. Barnes. "Phosphodiesterase expression in human epithelial cells". American Journal of Physiology-Lung Cellular and Molecular Physiology 275, nr 4 (1.10.1998): L694—L700. http://dx.doi.org/10.1152/ajplung.1998.275.4.l694.
Pełny tekst źródłaSasseville, M., F. K. Albuz, F. J. Richard i R. B. Gilchrist. "254. Evidences for a novel cAMP-phosphodiesterase expressed in the bovine ovarian follicle". Reproduction, Fertility and Development 20, nr 9 (2008): 54. http://dx.doi.org/10.1071/srb08abs254.
Pełny tekst źródłaNeumann, Joachim, Rafaela Voss, Ulrich Laufs, Christian Werner i Ulrich Gergs. "Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H2-histamine-receptor activation in isolated atria of transgenic mice". Naunyn-Schmiedeberg's Archives of Pharmacology 394, nr 6 (12.02.2021): 1215–29. http://dx.doi.org/10.1007/s00210-021-02052-y.
Pełny tekst źródłaTarpey, Siobhán B., Darrell R. Sawmiller, Claire Kelly, W. Joseph Thompson i Mary I. Townsley. "Phosphodiesterase 3 activity is reduced in dog lung following pacing-induced heart failure". American Journal of Physiology-Lung Cellular and Molecular Physiology 284, nr 5 (1.05.2003): L766—L773. http://dx.doi.org/10.1152/ajplung.00373.2002.
Pełny tekst źródłaPhillips, Peter G., Lu Long, Martin R. Wilkins i Nicholas W. Morrell. "cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling". American Journal of Physiology-Lung Cellular and Molecular Physiology 288, nr 1 (styczeń 2005): L103—L115. http://dx.doi.org/10.1152/ajplung.00095.2004.
Pełny tekst źródłaERDOGAN, Suat, i Miles D. HOUSLAY. "Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant". Biochemical Journal 321, nr 1 (1.01.1997): 165–75. http://dx.doi.org/10.1042/bj3210165.
Pełny tekst źródłaSzczypka, Marianna. "Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions". International Journal of Molecular Sciences 21, nr 17 (25.08.2020): 6118. http://dx.doi.org/10.3390/ijms21176118.
Pełny tekst źródłaTeng, Bunyan, Daniel N. Darlington i Andrew P. Cap. "Adenosine Regulation of cAMP through Phosphodiesterases". Blood 132, Supplement 1 (29.11.2018): 2424. http://dx.doi.org/10.1182/blood-2018-99-114929.
Pełny tekst źródłaGranovski, Olexiy, i Olena Boiarchuk. "FUNCTIONAL AND MUTATIONAL ANALYSIS OF THE IDENTIFICATION OF Pγ-BINDING RESIDUES ON PDE6α'". Grail of Science, nr 28 (22.06.2023): 157–61. http://dx.doi.org/10.36074/grail-of-science.09.06.2023.23.
Pełny tekst źródłaSeybold, Joachim, Dirk Thomas, Martin Witzenrath, Şengül Boral, Andreas C. Hocke, Alexander Bürger, Armin Hatzelmann i in. "Tumor necrosis factor-α–dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability". Blood 105, nr 9 (1.05.2005): 3569–76. http://dx.doi.org/10.1182/blood-2004-07-2729.
Pełny tekst źródłaManns, J. M., K. J. Brennan, S. B. Sheth i R. W. Colman. "Differential Regulation of Human Platelet Responses by cGMP Inhibited and Stimulated cAMP Phosphodiesterases". Thrombosis and Haemostasis 87, nr 05 (2002): 873–79. http://dx.doi.org/10.1055/s-0037-1613099.
Pełny tekst źródłaGermain, Nöella, Elisabeth Boichot, Jean-Michel Planquois i Vincent Lagente. "Reduced Airway Hyperresponsiveness by Phosphodiesterase 3 and 4 Inhibitors in Guinea-Pigs". Mediators of Inflammation 8, nr 3 (1999): 153–57. http://dx.doi.org/10.1080/09629359990487.
Pełny tekst źródłaŚwierczek, Artur, Krzysztof Pociecha, Hanna Plutecka, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa i Elżbieta Wyska. "Pharmacokinetic/Pharmacodynamic Evaluation of a New Purine-2,6-Dione Derivative in Rodents with Experimental Autoimmune Diseases". Pharmaceutics 14, nr 5 (19.05.2022): 1090. http://dx.doi.org/10.3390/pharmaceutics14051090.
Pełny tekst źródłaSarfati, Marika, Véronique Mateo, Sylvie Baudet, Manuel Rubio, Christine Fernandez, Fréderic Davi, Jacques-Louis Binet, Jozo Delic i Hélène Merle-Béral. "Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells". Blood 101, nr 1 (1.01.2003): 265–69. http://dx.doi.org/10.1182/blood-2002-01-0075.
Pełny tekst źródłaReid, Ian A. "Role of Phosphodiesterase Isoenzymes in the Control of Renin Secretion: Effects of Selective Enzyme Inhibitors". Current Pharmaceutical Design 5, nr 9 (styczeń 1999): 725–35. http://dx.doi.org/10.2174/1381612805666230111201536.
Pełny tekst źródłaAbusnina, Abdurazzag, Thérèse Keravis, Qingwei Zhou, Hélène Justiniano, Annelise Lobstein i Claire Lugnier. "Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition". Thrombosis and Haemostasis 113, nr 02 (marzec 2015): 319–28. http://dx.doi.org/10.1160/th14-05-0454.
Pełny tekst źródłaLee, Dong I., i David A. Kass. "Phosphodiesterases and Cyclic GMP Regulation in Heart Muscle". Physiology 27, nr 4 (sierpień 2012): 248–58. http://dx.doi.org/10.1152/physiol.00011.2012.
Pełny tekst źródłaFavot, Laure, Thérèse Keravis, Vincent Holl, Alain Bec i Claire Lugnier. "VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors". Thrombosis and Haemostasis 90, nr 08 (2003): 334–43. http://dx.doi.org/10.1160/th03-02-0084.
Pełny tekst źródłaMokra, Daniela, i Juraj Mokry. "Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?" International Journal of Molecular Sciences 22, nr 4 (16.02.2021): 1929. http://dx.doi.org/10.3390/ijms22041929.
Pełny tekst źródłaCheng, Jingfei, Michael A. Thompson, Henry J. Walker, Catherine E. Gray, Gina M. Warner, Wei Zhou i Joseph P. Grande. "Lixazinone Stimulates Mitogenesis of Madin-Darby Canine Kidney Cells". Experimental Biology and Medicine 231, nr 3 (marzec 2006): 288–95. http://dx.doi.org/10.1177/153537020623100308.
Pełny tekst źródłaOgawa, Ryosuke, Michael B. Streiff, Artem Bugayenko i Gregory J. Kato. "Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells". Blood 99, nr 9 (1.05.2002): 3390–97. http://dx.doi.org/10.1182/blood.v99.9.3390.
Pełny tekst źródłaCote, R. H. "Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5". International Journal of Impotence Research 16, S1 (czerwiec 2004): S28—S33. http://dx.doi.org/10.1038/sj.ijir.3901212.
Pełny tekst źródłaBloom, Timothy J. "Age-related alterations in cyclic nucleotide phosphodiesterase activity in dystrophic mouse leg muscle". Canadian Journal of Physiology and Pharmacology 83, nr 11 (1.11.2005): 1055–60. http://dx.doi.org/10.1139/y05-085.
Pełny tekst źródłaSpence, S., G. Rena, G. Sweeney i M. D. Houslay. "Induction of Ca2+/calmodulin-stimulated cyclic AMP phosphodiesterase (PDE1) activity in Chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms". Biochemical Journal 310, nr 3 (15.09.1995): 975–82. http://dx.doi.org/10.1042/bj3100975.
Pełny tekst źródłaWang, Ya-Juan, Shun-De Song, Jun-Chun Chen, Xue-Feng Wang, Ya-Li Jiang, Qiang-Min Xie, Ji-Qiang Chen, Zi-Gang Li i Hui-Fang Tang. "Effects of InactivatedBordetella pertussison Phosphodiesterase in the Lung of Ovalbumin Sensitized and Challenged Rats". Pulmonary Medicine 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/581738.
Pełny tekst źródłaMussen, Femke, Jana Van Broeckhoven, Niels Hellings, Melissa Schepers i Tim Vanmierlo. "Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury". International Journal of Molecular Sciences 24, nr 9 (2.05.2023): 8135. http://dx.doi.org/10.3390/ijms24098135.
Pełny tekst źródłaHovmöller, Sven, Linus Hovmöller Zou, Xiaodong Zou i Benjamin Grushko. "Structures of pseudo-decagonal approximants in Al−Co−Ni". Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 370, nr 1969 (28.06.2012): 2949–59. http://dx.doi.org/10.1098/rsta.2011.0310.
Pełny tekst źródłaIvey, F. Douglas, Lili Wang, Didem Demirbas, Christina Allain i Charles S. Hoffman. "Development of a Fission Yeast-Based High-Throughput Screen to Identify Chemical Regulators of cAMP Phosphodiesterases". Journal of Biomolecular Screening 13, nr 1 (26.11.2007): 62–71. http://dx.doi.org/10.1177/1087057107312127.
Pełny tekst źródłaTulsian, Nikhil K., Valerie Jia-En Sin, Hwee-Ling Koh i Ganesh S. Anand. "Development of Phosphodiesterase–Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity". International Journal of Molecular Sciences 22, nr 10 (15.05.2021): 5242. http://dx.doi.org/10.3390/ijms22105242.
Pełny tekst źródłaRickles, Richard J., Laura Pierce, Thomas Giordano, Winnie F. Tam, Douglas W. McMillin, Kenneth C. Anderson, Constantine Mitsiades i Margaret S. Lee. "Adenosine A2A Receptor Agonism and PDE Inhibition: A Synergistic Multi-Target Mechanism Discovered through Systematic Combination Screening in Multiple Myeloma". Blood 112, nr 11 (16.11.2008): 847. http://dx.doi.org/10.1182/blood.v112.11.847.847.
Pełny tekst źródłaFoureau, Anna V. Ivanina, David M. Foureau, Carol J. Farhangfar i Kathryn F. Mileham. "Abstract 281: Phosphodiesterase 8/9 inhibition to sensitize squamous non-small cell lung cancer (NSCLC) to pemetrexed (PMX): A double-edge strategy". Cancer Research 83, nr 7_Supplement (4.04.2023): 281. http://dx.doi.org/10.1158/1538-7445.am2023-281.
Pełny tekst źródłaZheng, Yang, Susanne Schroeder, Georgi K. Kanev, Sanaa S. Botros, Samia William, Abdel-Nasser A. Sabra, Louis Maes i in. "To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?" International Journal of Molecular Sciences 24, nr 7 (6.04.2023): 6817. http://dx.doi.org/10.3390/ijms24076817.
Pełny tekst źródłaNikawa, J., P. Sass i M. Wigler. "Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae". Molecular and Cellular Biology 7, nr 10 (październik 1987): 3629–36. http://dx.doi.org/10.1128/mcb.7.10.3629-3636.1987.
Pełny tekst źródłaNikawa, J., P. Sass i M. Wigler. "Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae." Molecular and Cellular Biology 7, nr 10 (październik 1987): 3629–36. http://dx.doi.org/10.1128/mcb.7.10.3629.
Pełny tekst źródłaXin, Wenkuan, Wei P. Feinstein, Andrea L. Britain, Cristhiaan D. Ochoa, Bing Zhu, Wito Richter, Silas J. Leavesley i Thomas C. Rich. "Estimating the magnitude of near-membrane PDE4 activity in living cells". American Journal of Physiology-Cell Physiology 309, nr 6 (15.09.2015): C415—C424. http://dx.doi.org/10.1152/ajpcell.00090.2015.
Pełny tekst źródłaKopanitsa, Liliya, Maksym V. Kopanitsa, Dewi Safitri, Graham Ladds i David S. Bailey. "Suppression of Proliferation of Human Glioblastoma Cells by Combined Phosphodiesterase and Multidrug Resistance-Associated Protein 1 Inhibition". International Journal of Molecular Sciences 22, nr 18 (7.09.2021): 9665. http://dx.doi.org/10.3390/ijms22189665.
Pełny tekst źródłaDay, Jonathan P., Miles D. Houslay i Shireen-A. Davies. "A novel role for a Drosophila homologue of cGMP-specific phosphodiesterase in the active transport of cGMP". Biochemical Journal 393, nr 2 (23.12.2005): 481–88. http://dx.doi.org/10.1042/bj20051505.
Pełny tekst źródłaMeima, Marcel E., Ricardo M. Biondi i Pauline Schaap. "Identification of a Novel Type of cGMP Phosphodiesterase That Is Defective in the ChemotacticstmFMutants". Molecular Biology of the Cell 13, nr 11 (listopad 2002): 3870–77. http://dx.doi.org/10.1091/mbc.e02-05-0285.
Pełny tekst źródłaHanson, Kimberly A., James W. Ziegler, Sergei D. Rybalkin, Jim W. Miller, Steven H. Abman i William R. Clarke. "Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity". American Journal of Physiology-Lung Cellular and Molecular Physiology 275, nr 5 (1.11.1998): L931—L941. http://dx.doi.org/10.1152/ajplung.1998.275.5.l931.
Pełny tekst źródłaMurray, Fiona, Hemal H. Patel, Ryan Y. S. Suda, Shen Zhang, Patricia A. Thistlethwaite, Jason X. J. Yuan i Paul A. Insel. "Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1". American Journal of Physiology-Lung Cellular and Molecular Physiology 292, nr 1 (styczeń 2007): L294—L303. http://dx.doi.org/10.1152/ajplung.00190.2006.
Pełny tekst źródłaBlanco-Rivero, Javier, i Fabiano E. Xavier. "Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases". Current Pharmaceutical Design 26, nr 30 (4.09.2020): 3633–51. http://dx.doi.org/10.2174/1381612826666200403172736.
Pełny tekst źródłaShen, Kunyu, David W. Johnson i Glenda C. Gobe. "The role of cGMP and its signaling pathways in kidney disease". American Journal of Physiology-Renal Physiology 311, nr 4 (1.10.2016): F671—F681. http://dx.doi.org/10.1152/ajprenal.00042.2016.
Pełny tekst źródłaOkatan, Esma N., i Belma Turan. "The contribution of phosphodiesterases to cardiac dysfunction in rats with metabolic syndrome induced by a high-carbohydrate diet". Canadian Journal of Physiology and Pharmacology 97, nr 11 (listopad 2019): 1064–72. http://dx.doi.org/10.1139/cjpp-2019-0006.
Pełny tekst źródłaWang, Huanchen, Stefan Kunz, Gong Chen, Thomas Seebeck, Yiqian Wan, Howard Robinson, Sibylla Martinelli i Hengming Ke. "Biological and Structural Characterization of Trypanosoma cruzi Phosphodiesterase C and Implications for Design of Parasite Selective Inhibitors". Journal of Biological Chemistry 287, nr 15 (21.02.2012): 11788–97. http://dx.doi.org/10.1074/jbc.m111.326777.
Pełny tekst źródłaMaronde, Erik. "Influence of Phosphodiesterase Inhibition on CRE- and EGR1-Dependent Transcription in a Mouse Hippocampal Cell Line". International Journal of Molecular Sciences 21, nr 22 (17.11.2020): 8658. http://dx.doi.org/10.3390/ijms21228658.
Pełny tekst źródłaSu, Yi-Hsien, i Victor D. Vacquier. "Cyclic GMP-specific Phosphodiesterase-5 Regulates Motility of Sea Urchin Spermatozoa". Molecular Biology of the Cell 17, nr 1 (styczeń 2006): 114–21. http://dx.doi.org/10.1091/mbc.e05-08-0820.
Pełny tekst źródłaMendoza, G. A., i F. Treves. "linear PDE". Duke Mathematical Journal 63, nr 2 (lipiec 1991): 355–77. http://dx.doi.org/10.1215/s0012-7094-91-06315-5.
Pełny tekst źródłaOliveira, Tiago Roux, i Miroslav Krstic. "Extremum seeking boundary control for PDE–PDE cascades". Systems & Control Letters 155 (wrzesień 2021): 105004. http://dx.doi.org/10.1016/j.sysconle.2021.105004.
Pełny tekst źródła